EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Surrogate Markers of Intestinal Permeability, Bacterial Translocation and Gut–Vascular Barrier Damage Across Stages of Cirrhosis

Frederic Haedge, Philipp A Reuken iD, Johanna Reißing, Karsten Große, Mick Frissen, Majda El-Hassani, Rene Aschenbach, Ulf Teichgräber, Andreas Stallmach, Tony Bruns iD

Liver International · 2025

DOI: 10.1111/liv.70119 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Liver International, 2025. Verfasst von Frederic Haedge und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine III, University Hospital RWTH Aachen, Aachen, Germany. Hauptthemen laut MEDLINE: Bacterial Translocation, Liver Cirrhosis, Intestinal Mucosa. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims Portal hypertension, gut barrier dysfunction, and pathological bacterial translocation are hallmarks of cirrhosis driving complications. As measuring gut barrier function is demanding, surrogate markers have been proposed, but their intercorrelation and applicability across different stages of advanced liver disease, particularly in acute‐on‐chronic liver failure (ACLF), are largely unknown.

Methods

Proposed markers of gut barrier dysfunction and bacterial translocation were quantified in sera from 160 patients with cirrhosis across different disease stages of compensated and decompensated cirrhosis as well as from 20 patients in hepatic and portal vein serum before and after the insertion of transjugular intrahepatic portosystemic stent (TIPS) using enzyme‐linked immunosorbent assay (ELISA).

Results

Across all stages of liver disease, the gut–vascular barrier (GVB) marker plasmalemma vesicle protein‐1 (PV‐1) correlated with bacterial translocation markers endogenous endotoxin‐core IgA antibodies (EndoCAb) and LPS‐binding protein (LBP) but not with intestinal damage markers intestinal fatty acid binding protein (I‐FABP) and zonulin‐family peptides (ZFP). PV‐1 and EndoCAb were higher in decompensated cirrhosis without further increase in ACLF. Among investigated markers, only I‐FABP correlated with the portosystemic pressure gradient, and TIPS insertion significantly reduced portal concentrations within 24 h. Higher PV‐1 levels indicated poor transplant‐free survival in univariate and multivariable analysis.

Conclusions

Surrogate markers of bacterial gut barrier dysfunction and bacterial translocation like ZFP, LBP and EndoCAb appear of limited use in advanced stages of cirrhosis and are confounded by hepatic synthesis capacity, portal congestion and acute phase responses. The prognostic implications of circulating PV‐1 in decompensated cirrhosis levels demand further investigation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bacterial TranslocationLiver CirrhosisIntestinal MucosaHumansBiomarkersMaleFemaleMiddle AgedFatty Acid-Binding ProteinsPermeabilityAcute-Phase ProteinsMembrane GlycoproteinsAgedCarrier ProteinsHypertension, PortalPortasystemic Shunt, Transjugular IntrahepaticAcute-On-Chronic Liver FailureHaptoglobinsMembrane ProteinsAdultEnzyme-Linked Immunosorbent AssayProtein PrecursorsImmunoglobulin A

Stichwörter der Autor:innen

acute‐on‐chronic liver failuregut–barrier dysfunctiongut–liver axisintestinal permeabilityleaky gutliver cirrhosis

Substanzen

BiomarkersFatty Acid-Binding ProteinsAcute-Phase ProteinsMembrane GlycoproteinsCarrier ProteinsHaptoglobinsMembrane ProteinsProtein PrecursorsImmunoglobulin ALipopolysaccharide-Binding Protein

Autor:innen und Institutionen

  • Department of Internal Medicine III, University Hospital RWTH Aachen, Aachen, Germany.
  • Department of Internal Medicine IV, Jena University Hospital, Friedrich Schiller University Jena, Jena, Germany.
  • Department of Radiology, Jena University Hospital, Friedrich Schiller University Jena, Jena, Germany.

ORCID-Profile: Philipp A Reuken, Tony Bruns

Förderung

  • Deutsche Forschungsgemeinschaft

Zitieren

APA

Haedge, F., Reuken, P. A., Reißing, J., Große, K., Frissen, M., El-Hassani, M., Aschenbach, R., Teichgräber, U., Stallmach, A., & Bruns, T. (2025). Surrogate Markers of Intestinal Permeability, Bacterial Translocation and Gut–Vascular Barrier Damage Across Stages of Cirrhosis. Liver International. https://doi.org/10.1111/liv.70119

Vancouver

Haedge F, Reuken PA, Reißing J, Große K, Frissen M, El-Hassani M, et al. Surrogate Markers of Intestinal Permeability, Bacterial Translocation and Gut–Vascular Barrier Damage Across Stages of Cirrhosis. Liver International. 2025. doi:10.1111/liv.70119

BibTeX
@article{Haedge2025,
  author = {Haedge, Frederic and Reuken, Philipp A and Reißing, Johanna and Große, Karsten and Frissen, Mick and El-Hassani, Majda and Aschenbach, Rene and Teichgräber, Ulf and Stallmach, Andreas and Bruns, Tony},
  title = {Surrogate Markers of Intestinal Permeability, Bacterial Translocation and Gut–Vascular Barrier Damage Across Stages of Cirrhosis},
  journal = {Liver International},
  year = {2025},
  doi = {10.1111/liv.70119}
}
Kostenlos starten →